发明名称 Treatment of mucosal membranes
摘要 The invention relates to the use of one or more antimicrobial metals preferably selected from silver, gold, platinum, and palladium but most preferably silver, formed with atomic disorder, and preferably in a nanocrystalline form, for reducing inflammation or infection of the mucosal membrane. The antimicrobial metal may be formulated as, or used in the form of, a nanocrystalline coating of one or more antimicrobial or noble metals, a nanocrystalline powder of one or more antimicrobial or noble metals, or a liquid or solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial or noble metals.
申请公布号 US2006204591(A1) 申请公布日期 2006.09.14
申请号 US20060434958 申请日期 2006.05.16
申请人 NUCRYST PHARAMACEUTICALS CORP., A CANADIAN CORPORATION 发明人 BURRELL ROBERT E.;NAYLOR ANTONY G.;MOXHAM PETER H.
分类号 A61K9/02;A61K33/24;A61K9/00;A61K9/06;A61K9/08;A61K9/10;A61K9/107;A61K9/12;A61K9/14;A61K9/16;A61K9/20;A61K9/51;A61K9/68;A61K9/70;A61K33/38;A61K33/40;A61K47/34;A61K47/38;A61L15/44;A61L15/46;A61L17/14;A61L27/30;A61L29/10;A61L31/08;A61P1/00;A61P1/02;A61P9/00;A61P11/00;A61P11/02;A61P11/04;A61P13/00;A61P13/08;A61P15/00;A61P17/00;A61P17/02;A61P17/04;A61P17/06;A61P17/08;A61P17/10;A61P19/00;A61P19/02;A61P27/16;A61P29/00;A61P31/00;A61P31/04;A61P31/10;A61P35/00;A61P43/00 主分类号 A61K9/02
代理机构 代理人
主权项
地址